Current Edition


Catalent’s FDA write-up spurred Novo Nordisk’s Wegovy supply woes

Catalent received an FDA write-up for its syringe filling facility in Belgium, BioProcess International reports, adding that it is “allegedly” the culprit behind supply challenges for …

Continue Reading →

E Ink and Faubel Unveil the Med Label to Revolutionize the Clinical Trial Supply Chain

The Smart Label Simplifies and Shortens Expiry Updates Allowing for Considerable Time and Cost Savings E Ink® Holdings, “E Ink” (8069.TW), the leading innovator of …

Continue Reading →